Catalyst OrthoScience

Naples, United States Founded: 2011 • Age: 15 yrs
A total shoulder implant solution is developed by Catalyst OrthoScience.

About Catalyst OrthoScience

Catalyst OrthoScience is a Healthcare company based in Naples (United States) founded in 2011. A total shoulder implant solution is developed by Catalyst OrthoScience. Catalyst OrthoScience has raised $69.29 million across 10 funding rounds from investors including Western Alliance Bank, Bridge Bank and River Cities Capital. The company has 17 employees. Catalyst OrthoScience offers products and services including Catalyst CSR Total Shoulder System, Catalyst Reverse Shoulder System, Catalyst Stemmed Anatomic, and Archer 3D Targeting Software. Its focus areas include Life Sciences, Orthopedics, Medical Devices and Therapies. Its competitors include Think Surgical, Waypoint Orthopedics and Viseon; 3 of its 3 listed competitors have raised funding.

Company details

Catalyst OrthoScience was founded in 2011 in Naples, United States, within the orthopedic medical device sector. The Catalyst CSR Shoulder System has been created as a bone-preserving and less invasive total shoulder implant. Indications include osteoarthritis, avascular necrosis, rheumatoid arthritis, post-traumatic arthritis, and functional deformity correction. FDA clearance has been obtained for this shoulder system, supporting clinical applications in the field.

  • Headquarters Naples, United States
  • Employees 17
  • Sectors
    Healthcare
  • Email
    β€’β€’β€’β€’β€’β€’β€’β€’
  • Phone
    β€’β€’β€’β€’ β€’β€’β€’β€’
  • Website catalystortho.com
  • Social LinkedIn X Facebook
Key Metrics
  • Total Equity Funding
    $69.29M (USD)

    in 10 rounds

  • Latest Funding Round
    $15M (USD), Series E

    Oct 2025

  • Investors
  • Employee Count
    17

Products & Services of Catalyst OrthoScience

Catalyst OrthoScience offers a comprehensive portfolio of products and services, including Catalyst CSR Total Shoulder System, Catalyst Reverse Shoulder System, Catalyst Stemmed Anatomic, and Archer 3D Targeting Software.

Catalyst CSR Total Shoulder System
Shoulder Implant

Provides anatomic shoulder replacement for improved range of motion.

Catalyst Reverse Shoulder System
Shoulder Implant

Simplifies reverse shoulder arthroplasty with single-tray efficiency.

Catalyst Stemmed Anatomic
Shoulder Implant

Offers stemmed anatomic options for shoulder surgery support.

Archer 3D Targeting Software
Surgical Software

Assists in precise targeting for orthopedic procedures.

Funding Insights of Catalyst OrthoScience

Catalyst OrthoScience has successfully raised a total of $69.29M across 10 strategic funding rounds. The most recent funding activity was a Series E round of $15 million completed in October 2025. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.

  • Total Funding $69.29M
  • Total Rounds 10
  • Last Round Series E β€” $15M
  • First Round $50,000

    (Dec 2015)

  • Investors Count 5

All 10 funding rounds of Catalyst OrthoScience with amounts and investors; the two latest post-money valuations are shown, the rest are part of the premium plan.

DateAmountTransaction NameValuationLead InvestorsInvestors
Oct 2025Debt – Conventional––
–
Oct 2025$15MSeries E–River Cities Capital
Jul 2025$4.14MSeries E––
–
Sep 2024$20MSeries E–Bridge Bank
Sep 2024Debt – Venture––
Apr 2024$1.5MSeries D––
–
Oct 2021$12.3MSeries D–Mutual Capital Partners, River Cities Capital
–
May 2019$12.7MSeries C–River Cities Capital
–
Nov 2017$3.6MSeries A––
–
Dec 2015$50,000Seed––
–
Valuation history

5 investors in total: 4 institutional and 1 angel.

Investors in Catalyst OrthoScience

Catalyst OrthoScience has secured backing from 5 investors, including venture fund, institutional, and angel investors. Prominent investors backing the company include Western Alliance Bank, Bridge Bank and River Cities Capital.

All
Venture Fund
Institutional
Angel
InvestorDescriptionFounded YearDomainLocation
rccf.com
mutualcapitalpartners.com
Commercial bank
2001bridgebank.comSan Jose, United States
Commercial banking services, including loans and treasury management, are provided.
2001westernalliancebancorporation.comPhoenix, United States

Derace L Schaffer

unknown_1fbeb919a25d4c739
Premium access

Investor details for Catalyst OrthoScience

The complete investor list, round-by-round participation and investor portfolios require an active premium plan.

  • Complete investor list
  • Round participation
  • Investor portfolios
  • Co-investor network

Verified entity values are shown only after access is granted.

People of Catalyst OrthoScience

19 people are tracked at Catalyst OrthoScience (16 in leadership, 3 in team); the tracked headcount is 17.

NameRoleGroup
Timothy Thompson
Senior Director - Clinical Affairs & Professional DevelopmentLeadership
Garrett Campbell
Vice President, Integrated Marketing And Business PlanningLeadership
Jason Ferris
Area Vice President - NorthLeadership
Ephraim Akyuz
Chief Technology OfficerLeadership
Matt Green
Director, Business IntelligenceLeadership
Todd Wilson
Vice President, Medical Education & DevelopmentLeadership
Carl O'Connell
President and CEOLeadership
Andrew Dromsky
Regional Sales DirectorLeadership
Amy Ables
Chief Commercial Officer (cco)Leadership
Nancy McCarroll
Chief Administrative Officer (cao)Leadership
Steven Goldberg
Founder And Chief Medical OfficerLeadership
Ryan Storck
Area Vice President, Northeast USLeadership
Jon Blackman
Senior Regional Sales DirectorLeadership
Todd Stegall
Area Vice President - SouthLeadership
Ian Thomas
Regional Sales DirectorLeadership
Bob Jacobs
Vice President SalesLeadership
Logan Morton
Senior Product Development EngineerTeam
Bob Koch
Accounting & Finance ManagerTeam
Tom Blank
Distributor PrincipalTeam
Premium access

Complete people profiles for Catalyst OrthoScience

Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.

  • Full employee list
  • Team structure
  • Board tenure
  • Professional contacts

Verified entity values are shown only after access is granted.

Timeline of Catalyst OrthoScience

3 dated milestones of Catalyst OrthoScience across 14 years, from founding to its latest funding, stage changes and deals.

  1. Founded Catalyst OrthoScience is founded.
  2. Funding First funding round of $50K.
  3. Funding Latest funding round, Series E, of $15.0M.

Competitors of Catalyst OrthoScience

Catalyst OrthoScience has 3 listed competitors in our database, 3 of them funded. They include Think Surgical, Waypoint Orthopedics and Viseon.

Company NameDomainFoundedHQ LocationTotal fundingEmployeesDescription
thinksurgical.com2007Fremont, United States$13.2M
Image-directed robotic systems for orthopedic surgeries are developed.
waypointorthopedics.com2020Philadelphia, United States$3.14M
Decision support solutions for orthopedic surgery are provided.
viseon-inc.com2017Irvine, United States$29.45M
Digital visualization solutions for surgeons are provided by Viseon.
Premium access

Detailed competitors of Catalyst OrthoScience

The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.

  • Full competitor set
  • Operating metrics
  • Benchmarks
  • Competitive positioning

Verified entity values are shown only after access is granted.

Web traffic of Catalyst OrthoScience

The website of Catalyst OrthoScience (catalystortho.com) receives about 5.1K visits a month.

  • Monthly visits
    5.1K

    ▲ 25.7% vs previous month

Top companies in Orthopedics

3 companies that operate in the same segment as Catalyst OrthoScience (Orthopedics) in United States, ranked by their profile score on The Company Check.

CompanyDescriptionFoundedLocationTotal fundingRevenueEmployees
Provider of high-frequency spinal cord stimulation implants
2006Menlo Park, California, United StatesUSD 154.1 MUSD 353.08 M1,215
Developer of therapies for the treatment of musculoskeletal disorders
2007Woburn, Massachusetts, United StatesUSD 62 MUSD 85.55 M692
Antibody-siRNA complexes are developed for cancer treatment.
2012San Diego, California, United StatesUSD 142.54 MUSD 10.9 M391
Upgrade to premium

Unlock complete access to The Company Check

Get unrestricted viewing across everything we track β€” from companies and brands to investors, funding rounds, acquisitions, financials, and more.

Upgrade to Premium No viewing limits. Your plan controls exports and screening usage.
Included in your Premium account
  • βœ“
    Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
  • βœ“
    Full access to every database India & global coverage, advanced filters and rich profile details
  • βœ“
    Always-on access from your team account Single premium plan for everything you see on the portal

Related news about Catalyst Orthoscience

Premium access

Complete news archive for Catalyst OrthoScience

Full article history, source details, and older brand coverage require an active premium plan.

  • Full article archive
  • Source and publication date
  • Older coverage
  • Brand-specific news history

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Catalyst OrthoScience

Catalyst OrthoScience was founded in 2011 and raised its 1st funding round 4 years after it was founded.

Catalyst OrthoScience is headquartered in Naples, United States. It is registered at Naples, Florida, United States.

Catalyst OrthoScience is a funded company, having raised a total of $69.29M across 10 funding rounds to date. The company's 1st funding round was a Seed of $50K, raised on Dec 2015.

Catalyst OrthoScience has 17 employees.

Catalyst OrthoScience was founded in 2011 in Naples, United States, within the orthopedic medical device sector. The Catalyst CSR Shoulder System has been created as a bone-preserving and less invasive total shoulder implant. Indications include osteoarthritis, avascular necrosis, rheumatoid arthritis, post-traumatic arthritis, and functional deformity correction. FDA clearance has been obtained for this shoulder system, supporting clinical applications in the field.

Catalyst OrthoScience's top competitors include Think Surgical, Viseon and Waypoint Orthopedics.

Catalyst OrthoScience offers Catalyst CSR Total Shoulder System, Catalyst Reverse Shoulder System, Catalyst Stemmed Anatomic, and Archer 3D Targeting Software.

Catalyst OrthoScience has 5 investors. Key investors include Western Alliance Bank, Bridge Bank, River Cities Capital, Mutual Capital Partners, and Derace L Schaffer.

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available